 <!-- ****************** Find the errors in the html start ****************** -->
    <!-- <div style="border: 1px solid #000001; padding: 2px, margin-bottom: 5px;"><b>WARNING: RISK OF SERIOUS HARM OR DEATH WITH INTRAVENOUS ADMINISTRATION; SUBLOCADE RISK EVALUATION AND MITIGATION STRATEGY</b><br><b>•  Serious harm or death could result if administered intravenously. SUBLOCADE forms a solid mass upon contact with body fluids and may cause occlusion, local tissue damage, and thrombo-embolic events, including life threatening pulmonary emobli, if administered intravenously.</b></div><br><b>IMPORTANT SAFETY INFORMATION</b><br><br>Prescription use of this product is limited under the Drug Addiction Treatment Act.<br><br><b>CONTRAINDICATIONS</b><br><br>SUBLOCADE should not be administered to patients who have been shown to be hypersensitive to buprenorphine or any component of the ATRIGEL<sup>®<sup> delivery system<br><br><b>Please click here to full <a href="https://www.sublocade.com/Content/pdf/prescribing-information.pdf" target="_blank>Prescribing Information</a>, including BOXED WARNING</b> -->

        <!-- inline styles not the best way to style.-->
        <!-- strong tags should be used over b tag -->
        <!-- use ul to list items for bullets -->
        <!-- use head tag for the title message -->
        <!-- some text isn't inside any tags -->
        <!-- delivery system is superscriped -->
        <!-- target is missing a " at the end -->
<!-- ****************** Find the errors in the html end ****************** -->

<!-- ****************************************************************************************** -->

    <!-- ****************** my version starts ****************** -->
<style>
       .border-content {
            border: 1px solid #000001;
            padding: 2px;
            margin-bottom: 5px;
        }
    </style>
    <section class="border-content">
        <h2><strong>WARNING: RISK OF SERIOUS HARM OR DEATH WITH INTRAVENOUS ADMINISTRATION; SUBLOCADE RISK EVALUATION AND MITIGATION STRATEGY</strong></h2>
    <ul>
        <li><strong>Serious harm or death could result if administered intravenously. SUBLOCADE forms a solid mass upon contact with body fluids and may cause occlusion, local tissue damage, and thrombo-embolic events, including life threatening pulmonary emobli, if administered intravenously.</strong></li>
    </ul>
    </section>
    <section>
        <h2><strong>IMPORTANT SAFETY INFORMATION</strong></h2>
        <p>Prescription use of this product is limited under the Drug Addiction Treatment Act.</p>
    </section>
    <section>
        <h2><strong>CONTRAINDICATIONS</strong></h2>
        <p>SUBLOCADE should not be administered to patients who have been shown to be hypersensitive to buprenorphine or any component of the ATRIGEL<sup>®</sup> delivery system</p>
        <p>Please click here to full <a href="https://www.sublocade.com/Content/pdf/prescribing-information.pdf" target="_blank">Prescribing Information</a> including BOXED WARNING</p>
    </section>


   